2 results match your criteria: "Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.[Affiliation]"
Article Synopsis
- The study aimed to investigate the differences in risk factors and biomarkers between atrial fibrillation (AF) and heart failure (HF) among nearly 59,000 individuals without either condition, monitored for around 14 years.
- Findings revealed that while common factors like age, male sex, and certain biomarkers were linked to both AF and HF, some factors, such as antihypertensive medication and smoking, were more strongly associated with HF.
- The research concluded that HF had a higher population-attributable risk and mortality link compared to AF, emphasizing the need for improved prevention strategies, as traditional risk factors only accounted for a small portion of AF risk.
Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
J Am Heart Assoc
April 2020
Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.
Background Risk stratification among patients with coronary artery disease (CAD) is of considerable interest due to the potential to guide secondary preventive therapies. Thus, we evaluated the predictive value of soluble urokinase-type plasminogen activator receptor (suPAR) levels for cardiovascular mortality and nonfatal myocardial infarction in patients with CAD. Methods and Results Plasma levels of suPAR were measured in a cohort of 1703 patients with documented CAD as evidenced by coronary angiography-including 626 patients with acute coronary syndrome and 1077 patients with stable angina pectoris.
View Article and Find Full Text PDF